Clinical Trials
19 trialsNCT04308642 2024-05-16
Kid-MaCareOnco
University Hospital, Basel, Switzerland
Completed
NCT04574050 2024-03-19
SELF-BREATHE RCT for Chronic Breathlessness
King's College Hospital NHS Trust
Phase NA Completed
NCT04594161 2024-02-28
STONE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT02303015 2023-11-21
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
Rigshospitalet, Denmark
Completed
NCT03234335 2023-05-06
IRMYG
Centre Hospitalier Universitaire de Saint Etienne
Completed
NCT01429038 2022-06-14
Mesenchymal Stem Cells After Renal or Liver Transplantation
University of Liege
Phase 1/2 Completed
NCT00634504 2022-06-06
LVPK
BTG International Inc.
Phase 1 Completed
NCT02424851 2022-01-27
OPTIMAL
Oxford University Hospitals NHS Trust
Phase 2 Completed
NCT02668250 2021-08-26
OPTI-AGED
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Completed
NCT00854139 2020-03-04
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
Massachusetts General Hospital
Phase 1 Completed
NCT01832922 2018-03-30
BR in Patients With CLL With Comorbidities and/or Renal Dysfunction
Dartmouth-Hitchcock Medical Center
Phase 1 Completed
NCT01270932 2017-12-29
Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients
University Health Network, Toronto
Phase 2 Completed
NCT00779922 2016-10-11
Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function
Poitiers University Hospital
Phase 2 Completed
NCT00700531 2016-10-05
EuLITE
University Hospital Birmingham
Phase NA Completed
NCT01084837 2015-09-17
RENVEL
PETHEMA Foundation
Phase 2 Completed
NCT02491580 2015-07-08
Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer
Uppsala University
Completed
NCT00219791 2014-09-11
Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance
BTG International Inc.
Phase 2 Completed
NCT00401804 2013-01-24
Bortezomib-Dexamethasone-Doxorubicin-Study
Austrian Forum Against Cancer
Phase 2 Completed
NCT00325611 2006-05-15
Multidisciplinary Inpatient Palliative Care Intervention
Kaiser Permanente
Phase NA Completed